Mr. Stephen Davis reports

FREQUENCY EXCHANGE CORP. APPOINTS GAIL EDGELL TO ADVISORY BOARD

Frequency Exchange Corp. has appointed Gail Edgell to its advisory board.

Ms. Edgell brings over 25 years of experience in the wellness industry, with leadership roles across corporate wellness, professional supplements, biotechnology start-ups and integrative clinical consulting. She has held strategic positions focused on market development, practitioner engagement and education-based commercialization, contributing to consistent revenue growth across several companies.

Her career includes senior contributions at Designs for Health, where she helped scale practitioner channel sales from $360,000 to $1.5-million in under three years, and at Bio-Botanical Research, where she launched a practitioner partnership model that reached $1-million in annualized revenue within 90 days. Ms. Edgell has also supported business development efforts at Panaceutics Nutrition, a biotech start-up, and has advised numerous integrative health clinics on operational growth and patient education strategies.

"Gail brings a deep understanding of the wellness practitioner ecosystem and how to build lasting commercial and educational relationships in that space," said Stephen Davis, chief executive officer of Frequency Exchange. "Her insights will support our efforts to scale Nikki's reach into professional, consumer and community-based health channels."

Ms. Edgell is also a published author, founder of Inside Out Wellness, and a former non-profit executive who led wellness-focused programs serving over 300 organizations and communities. She continues to collaborate with leading nutrition companies and health care educators to reimagine practitioner support experiences.

About Frequency Exchange Corp.

Frequency Exchange is the parent company of FREmedica Technologies Inc., a developer and commercializer of frequency-based digital wellness technologies. The company's flagship product, Nikki, delivers programmable frequency wellness programs designed to support cellular communication and overall well-being.

Originally developed to support those with Lyme disease, the Nikki platform has evolved to address broader use cases, including sleep, pain, energy, immune support and athletic recovery. The company's technology is supported by continuing testing and quality-of-life evaluations.

We seek Safe Harbor.